MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

LTC gained more than 12% in the past 24 hours, following two major institutional announcements. First and foremost, Luxxfolio ...

GSR announced an investment and strategic partnership with MEI Pharma in which it will serve as both strategic advisor and ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.

MEI Pharma, Inc. (NASDAQ:MEIP) saw its stock more than double following the announcement of a $100 million private placement ...

MEI Pharma, Inc. (NASDAQ:MEIP) is one of the hot penny stocks to invest in now. On July 18, MEI Pharma, Inc. (NASDAQ:MEIP) ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting ...

Meanwhile, MEI Pharma, a clinical-stage pharmaceutical company, has reported a net income of $17.8 million and revenues of $65.3 million for the fiscal year ended June 30, 2024. The company has also ...

SAN DIEGO-- (BUSINESS WIRE)--MEI Pharma, Inc. (NASDAQ: MEIP) (the “Company”) today announced that, based on a count of the votes cast at the Company’s Special Meeting of Stockholders, MEI, by a narrow ...

MEI Pharma stockholders and proxyholders will be able to attend and participate in the reconvened annual meeting online, be deemed to be present in person and vote their shares electronically, and ...

In a challenging market environment, MEI Pharma Inc (NASDAQ: NASDAQ: MEIP) stock has touched a 52-week low, reaching a price level of $2.54. With a market capitalization of just $17.66 million, the ...